These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3066419)

  • 21. [Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients].
    Sós I; Kiss N; Csorba J; Gerevich J
    Orv Hetil; 2000 Apr; 141(15):783-6. PubMed ID: 10808729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients.
    Koyuncuoglu H
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):13-9. PubMed ID: 7711985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clonidine as a drug in the treatment of heroin addicts].
    van Epen JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(41):1870-2. PubMed ID: 7144955
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intrahospital treatment of acute opiate withdrawal syndrome using the non-opiate agent clonidine].
    Cerdeño V; Pintado R; García de Lorenzo A; Galván B; Aguado A
    Med Clin (Barc); 1983 Oct; 81(11):472-4. PubMed ID: 6656347
    [No Abstract]   [Full Text] [Related]  

  • 25. Clonidine improved laboratory-measured decision-making performance in abstinent heroin addicts.
    Zhang XL; Wang GB; Zhao LY; Sun LL; Wang J; Wu P; Lu L; Shi J
    PLoS One; 2012; 7(1):e29084. PubMed ID: 22291886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary assay of clonidine in opiate withdrawal. Results of an open-study (author's transl)].
    Cottereau MJ; Antebi M; Benyacoub A; Loo H; Roux JM; Deniker P
    Nouv Presse Med; 1979 Oct; 8(40):3267. PubMed ID: 534186
    [No Abstract]   [Full Text] [Related]  

  • 27. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison.
    Kasvikis Y; Bradley B; Gossop M; Griffiths P; Marks I
    Int J Addict; 1990 Oct; 25(10):1169-78. PubMed ID: 2090621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
    Lintzeris N; Bell J; Bammer G; Jolley DJ; Rushworth L
    Addiction; 2002 Nov; 97(11):1395-404. PubMed ID: 12410780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
    Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
    Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of acetorphan with clonidine for opiate withdrawal symptoms.
    Hartmann F; Poirier MF; Bourdel MC; Loo H; Lecomte JM; Schwartz JC
    Am J Psychiatry; 1991 May; 148(5):627-9. PubMed ID: 2018165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine for acute heroin detoxification: diffusion of research into practice.
    Kovas AE; McFarland BH; McCarty DJ; Boverman JF; Thayer JA
    J Subst Abuse Treat; 2007 Mar; 32(2):199-206. PubMed ID: 17306728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of clonidine suppression of opiate withdrawal reactions: a multidisciplinary approach.
    Cuthill JD; Beroniade V; Salvatori VA; Viguié F
    Can J Psychiatry; 1990 Jun; 35(5):377-82. PubMed ID: 2372746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of heroin addiction.
    Jolliffe DW; Melville AW
    J R Coll Gen Pract; 1983 Jun; 33(251):368. PubMed ID: 6887104
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
    McGregor C; Ali R; White JM; Thomas P; Gowing L
    Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts.
    Camí J; Gilabert M; San L; de la Torre R
    Br J Addict; 1992 Aug; 87(8):1145-51. PubMed ID: 1511228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure monitoring at home for rapid opioid withdrawal with clonidine and naltrexone.
    Brewer C
    Lancet; 1987 Mar; 1(8533):621. PubMed ID: 2881149
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of clonidine in the treatment of morphine withdrawal syndrome: neuropharmacological bases and clinical application].
    Gurpegui M; Sweeney DR; Gold MS
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983; 11(3):253-8. PubMed ID: 6687343
    [No Abstract]   [Full Text] [Related]  

  • 40. Opiate withdrawal: inpatient versus outpatient programmes.
    Brewer C
    Br Med J (Clin Res Ed); 1986 Aug; 293(6543):391. PubMed ID: 3089534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.